深圳商报·读创客户端记者 张弛 北交所网站显示，12月29日，彩客科技披露了对北交所第二轮问询函的回复。文件显示，在问询函中，北交所围绕业绩增长合理性、销售真实性、关 联交易公允性问题逐一展开问询。 | 文件名称 | 披露日期 | | --- | --- | | 彩客科技:天健会计师事务所关于彩客科技第二轮问询的回复 | 2025-12-29 | | 彩客科技:彩客科技及中泰证券关于第二轮问询的回复 | 2025-12-29 | | 彩客科技:关于河北彩客新材料科技股份有限公司公开发行股票并在北交所上市申请文件的第 二轮审核问询函 | 2025-11-06 | | 彩客科技:竞天公诚律所关于彩客科技补充法律意见书（一） | 2025-10-23 | | 彩客科技:彩客科技及中泰证券关于第一轮问询的回复 门 | 2025-10-23 | | 彩客科技:天健会计师事务所关于彩客科技第一轮问询的回复 | 2025-10-23 | | 彩客科技:关于河北彩客新材料科技股份有限公司公开发行股票并在北交所上市申请又件的审 核问询函 | 2025-07-18 | 来源：北交所网站 据悉，德国辉柏赫曾是全球第二大颜料生产商， ...

Group 1 - The company is a globally recognized manufacturer of dye and agricultural chemical intermediates, pigment intermediates, new materials, and battery materials, with a history dating back to 1986 and a workforce of 2,000 employees [1] - The company has maintained a revenue compound annual growth rate (CAGR) of 10% from 2015 to 2024, with a shift in revenue structure where the share of dye and agricultural chemical intermediates has decreased while the share of pigment intermediates, new materials, and battery materials has increased [1] - The company is positioned as a leading domestic enterprise in iron phosphate battery materials and is steadily ramping up production and sales of its new product BPDA [1] Group 2 - In 2023, the company's net profit attributable to shareholders decreased by 88% year-on-year due to global economic factors, but it is projected to turn positive again in the first half of 2025 [2] - The company's net profits from 2020 to the first half of 2025 are recorded as 1.45, 2.26, 2.42, 0.29, -0.21, and 0.09 million yuan respectively, indicating a recovery strategy focusing on traditional industries and expanding new materials [2] - The company is actively adjusting its business strategy to strengthen its market position in traditional industries while increasing research and development efforts to stabilize market share and gradually restore profitability [2]

Core Viewpoint - Hebei Caike New Materials Technology Co., Ltd. (referred to as "Caike Technology") is facing scrutiny from the Beijing Stock Exchange regarding the sustainability of its high growth, sales authenticity, and fairness of related party transactions, particularly in light of a significant revenue increase driven by short-term orders following the bankruptcy of German competitor Huber [1][2]. Financial Performance - For 2024, Caike Technology projects revenue of 454 million yuan and a net profit of 113 million yuan, representing year-on-year growth of 20.6% and 44.0%, respectively [1]. - The revenue increase is largely attributed to the demand surge for DMSS and DATA intermediates due to Huber's market exit, raising concerns about the stability of this demand and potential post-2025 performance decline [1]. Customer and Revenue Recognition - Wenzhou Jinyuan remains the largest customer, accounting for 29%-32% of total revenue. The company initially recognized revenue on a "ship first, contract later" basis, which was later changed to an "annual framework + monthly settlement" model starting May 2025 [1][2]. - Regulatory authorities have requested detailed information on revenue recognition practices and the effectiveness of internal controls related to sales to Wenzhou Jinyuan [2]. Related Party Transactions - From 2022 to the first half of 2025, the company’s related party procurement amounts were 69.12 million yuan, 75.16 million yuan, 66.76 million yuan, and 35.67 million yuan, constituting 28%-33% of operating costs [2]. - The majority of related party purchases were for steam and wastewater treatment services from a related entity, raising questions about the rationale and fairness of these transactions [2]. Capital Expenditure and Production Capacity - The company plans to raise 210 million yuan for various expansion projects, including increasing production capacity for DMS, DMSS, and DATA [3]. - Despite the anticipated high growth in 2024, production capacity utilization rates for major products are expected to drop significantly to below 70% in the first half of 2025 [3][4]. Production Metrics - The production capacity utilization rates for DMSS, DMAS, and DATA in the first half of 2025 are projected to be 63.46%, 69.58%, and 62.07%, respectively, indicating a substantial decline from previous years [4].

Group 1 - The report highlights the selection of 12 innovative companies from the North Exchange, focusing on their strong technological attributes and scarcity in the market, with an average revenue of 582 million yuan and an average net profit of 72.05 million yuan for 2024 [2][4][10] - Key selected companies include: - Caike Technology: A specialized fine chemical "little giant" with expected revenue of 454 million yuan and net profit of 115.64 million yuan in 2024 [2][3] - Meikang Co., Ltd.: A leader in medical knowledge base construction, with expected revenue of 245 million yuan and net profit of 91.09 million yuan in 2024 [2][3] - Aikem: A "little giant" in pre-dispersed rubber additives, with expected revenue of 516 million yuan and net profit of 84.22 million yuan in 2024 [2][3] - Fuyin New Materials: A "little giant" in precision functional materials, with expected revenue of 724 million yuan and net profit of 81.83 million yuan in 2024 [3][4] - Tianjian New Materials: A leading company in high-performance modified plastics, with expected revenue of 1.129 billion yuan and net profit of 63.52 million yuan in 2024 [3][4] - Juxin Technology: A "little giant" in semiconductor power devices, with expected revenue of 564 million yuan and net profit of 54.53 million yuan in 2024 [3][4] - Tiniou Technology: Focused on semiconductor cleaning equipment, with expected revenue of 148 million yuan and net profit of 49.08 million yuan in 2024 [3][4] Group 2 - The North Exchange has a rich reserve of new productivity companies, including 189 companies accepted for listing, covering high-end equipment manufacturing, TMT, chemical new materials, consumption, and biomedicine [1][10][13] - Among the companies awaiting approval, 153 are in various stages, with the highest number in high-end equipment (54 companies) and TMT (28 companies), showing an average revenue of 830 million yuan and net profit of 95.79 million yuan for 2024 in the high-end equipment sector [1][13][14] - The report emphasizes the importance of innovation and technology in driving industrial growth and enhancing productivity, aligning with government initiatives to promote a modern industrial system [10][12]

Core Viewpoint - The article discusses the IPO acceptance of Hebei Caike New Materials Technology Co., Ltd. on the Beijing Stock Exchange, aiming to raise 210 million yuan for various expansion and upgrade projects, including the production of key chemical materials [1][7]. Summary by Sections Company Overview - Hebei Caike New Materials Technology Co., Ltd. was established in 2005 and became a joint-stock company in 2021, focusing on the R&D, production, and sales of fine chemical products. It is recognized as a national-level specialized and innovative "little giant" enterprise [7]. Financial Performance - The company's projected revenues for 2022, 2023, and 2024 are approximately 360 million yuan, 380 million yuan, and 450 million yuan, respectively. Net profits are expected to be 83.14 million yuan, 84.86 million yuan, and 115.64 million yuan, with gross profit margins increasing from 30.61% to 36.11% over the same period [9]. Production Capacity and Utilization - Current production capacities include 15,000 tons/year of DMS, 4,500 tons/year of DMSS, and 2,000 tons/year of DATA. The company also produces 5,000 tons/year of DMAS. The capacity utilization rates for DMS, DMSS, DATA, and DMAS have shown significant improvement from 2022 to 2024, with DMSS reaching 98.22% and DATA exceeding 100% in 2024 [8][10]. Product Expansion Plans - The company plans to expand its production capacity for DMS, DMSS, and DATA, including a new project to produce 500 tons/year of BPDA, a key monomer for high-end electronic-grade polyimide films. This expansion is expected to enhance the company's competitive position in the high-end polyimide monomer market, which is currently dominated by international giants [2][4]. Market Position - The high-end polyimide monomer market is primarily led by companies like DuPont and Mitsubishi Chemical, with domestic competitors including Hebei Hailihengyuan New Materials and Shanghai Guchuang Chemical New Materials. The article highlights the active financing of some domestic players, indicating a growing interest in this sector [4][5].